申请人:Tetra Discovery Partners, LLC
公开号:US20200354384A1
公开(公告)日:2020-11-12
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.